Update on Gestational Hypertension
نویسندگان
چکیده
منابع مشابه
Update on gestational diabetes.
As the rate of obesity increases in adolescent and adult women in the United States, practitioners of obstetrics see higher rates of gestational diabetes. Recent clinical studies suggest that women with gestational diabetes have impaired pancreatic beta-cell function and reduced beta-cell adaptation resulting in insufficient insulin secretion to maintain normal glycemia. Despite recent evidence...
متن کاملGestational Trophoblastic Disorders: An Update
Gestational trophoblastic diseases (GTD) are a group of pregnancy-related disorders representing rare human tumours. They encompass premalignant disorders including complete (CHM), partial hydatidiform mole (PHM), exaggerated placental site (EPS), and placental-site nodule (PSN) as well as malignant disorders (also known as “gestational trophoblastic neoplasia [GTN]”) including invasive mole, c...
متن کاملEuropean Society of Hypertension Scientific Newsletter: Update on Hypertension Management
Introduction Stroke is the third most frequent cause of death after cancer and heart disease in developed countries and one of the most common reasons for developing cognitive impairment and vascular dementia [1]. High blood pressure (BP) is a major risk factor for stroke, and a continuous relationship between BP and the occurrence of stroke has been well established [2]. On the other hand, evi...
متن کاملEuropean Society of Hypertension Scientific Newsletter: Update on Hypertension Management
Introduction Type 2 diabetes is a prevalent and important cardiovascular risk factor [1], and it is well known that patients with established diabetes run a cardiovascular risk between two and four times greater than that run by non-diabetics. It is therefore of importance to prevent the development of type 2 diabetes if possible by an appropriate lifestyle and by a careful selection of antihyp...
متن کاملEuropean Society of Hypertension Scientific Newsletter: Update on Hypertension Management
Introduction Angiotensin converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) are recommended as first-line therapy for hypertension in patients with chronic kidney disease (CKD). The relevant evidence extends from background studies showing that blood pressure (BP) reduction with agents that block the renin–angiotensin–aldosterone system (RAAS) yielded greater structur...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Women's Health
سال: 2006
ISSN: 1745-5065,1745-5065
DOI: 10.2217/17455057.2.5.695